Inventor · disambiguated record
Christopher W. Plummer
Also filed as: PLUMMER CHRISTOPHER W
18 granted patents·6 pending applications·30 citations·filing 2002–2025
90Inventor score
Top patents by PatentIndex Score
24 records- 0190US11230543B2Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2020·Granted Jan 25, 2022·2 cites·20 claims
- 0288US11312719B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME·Filed 2019·Granted Apr 26, 2022·4 cites·25 claims
- 0386US9957219B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·5 cites·13 claims
- 0482US10100042B2[5,6]—fused bicyclic antidiabetic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Oct 16, 2018·3 cites·13 claims
- 0581US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 0678US9527875B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·4 cites·13 claims
- 0775US7057051B2Substituted imidazoles as cannabinoid receptor modulatorsMERCK & CO INC·Filed 2002·Granted Jun 6, 2006·7 cites·8 claims
- 0873US7572785B2Substituted imidazoles as cannabinoid receptor modulatorsMERCK & CO INC·Filed 2005·Granted Aug 11, 2009·1 cites·8 claims
- 0972US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1071US12060357B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2022·Granted Aug 13, 2024·0 cites·28 claims
- 1167US10968193B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Apr 6, 2021·1 cites·11 claims
- 1266US9840512B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·23 claims
- 1365US2025152658A1Cyclic peptide for trapping interleukin-1 betaMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1462US11161819B2Substituted tetrahydroisoquinoline compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2020·Granted Nov 2, 2021·0 cites·17 claims
- 1560US12466831B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 11, 2025·0 cites·14 claims
- 1660US2023406885A1Cyclic peptides for trapping interleukin-1 betaMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1759US2025171447A1Adenosine receptor antagonists, pharmaceutical compositions and their use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1854US2019161448A1Substituted tetrahydroisoquinoline compounds useful as gpr120 agonistsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1954US2018339983A1Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 2042US7091211B2Cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Aug 15, 2006·0 cites·20 claims
- 2136US10662171B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted May 26, 2020·0 cites·15 claims
- 2234US10059667B2Antidiabetic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Aug 28, 2018·0 cites·11 claims
- 2334US10000454B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·22 claims
- 2431US10131651B2[7,6]-fused bicyclic antidiabetic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Nov 20, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Christopher W. Plummer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →